BlueWillow Biologics® is developing and enabling a new generation of safe and effective nasal vaccines to protect global populations from respiratory infections, sexually transmitted diseases, and food allergies. Our novel intranasal NanoVax® adjuvant platform activates mucosal immunity, the body’s first line of defense, while also inducing systemic immunity. We are a clinical-stage company advancing a […]
Location: United States, Michigan, Ann Arbor
Total raised: $10M
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 07.05.2018 | Series A | $10M | - |
Mentions in press and media 4
| Date | Title | Description | Source |
| 03.12.2018 | 5 Startup Trends that Shaped the Midwest in 2018 1. Marketp... | 2018 is quickly drawing to its close, but the Midwest’s venture capital activity is still buzzing. J... | hpa.vc/5-s... |
| 29.11.2018 | 5 startup trends that shaped the Midwest in 2018 | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI an... | venturebea... |
| 29.11.2018 | 5 startup trends that shaped the Midwest in 2018 | 2018 is quickly drawing to its close, but the Midwest’s venture capital activity is still buzzing. J... | venturebea... |
| 07.05.2018 | BlueWillow Biologics Closes $10M Series A Financing | NanoBio Corporation, an Ann Arbor, Mich.-based clinical-stage biopharmaceutical company, changed its... | finsmes.co... |